Teton Advisors Inc. Has $549,000 Stake in Electromed, Inc. $ELMD

Key Points

• Teton Advisors Inc. reduced its stake in Electromed, Inc. by 34.6% in Q1, now holding 23,000 shares valued at $549,000.
• Several institutional investors increased their holdings in Electromed, with Northern Trust Corp boosting its stake by 14.1% in the fourth quarter.
• Electromed has received strong support from analysts, with a consensus rating of "Strong Buy" and an average target price of $33.50.

Teton Advisors Inc. decreased its position in Electromed, Inc. (NYSE:ELMD - Free Report) by 34.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,000 shares of the company's stock after selling 12,142 shares during the quarter. Teton Advisors Inc. owned about 0.27% of Electromed worth $549,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE boosted its position in Electromed by 179.2% during the fourth quarter. Bank of America Corp DE now owns 4,004 shares of the company's stock worth $118,000 after purchasing an additional 2,570 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in Electromed during the fourth quarter worth approximately $119,000. Quantbot Technologies LP boosted its position in Electromed by 57.7% during the first quarter. Quantbot Technologies LP now owns 5,301 shares of the company's stock worth $126,000 after purchasing an additional 1,939 shares during the period. Tower Research Capital LLC TRC boosted its position in Electromed by 426.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,055 shares of the company's stock worth $149,000 after purchasing an additional 4,095 shares during the period. Finally, Russell Investments Group Ltd. boosted its position in Electromed by 557.0% during the first quarter. Russell Investments Group Ltd. now owns 7,969 shares of the company's stock worth $186,000 after purchasing an additional 6,756 shares during the period. Institutional investors own 40.82% of the company's stock.

Electromed Stock Up 0.8%

Shares of ELMD stock traded up $0.20 during trading hours on Friday, reaching $24.73. 79,825 shares of the company's stock were exchanged, compared to its average volume of 84,013. The business has a fifty day moving average price of $19.89 and a 200-day moving average price of $22.13. The stock has a market capitalization of $206.47 million, a P/E ratio of 32.97 and a beta of 0.38. Electromed, Inc. has a fifty-two week low of $15.06 and a fifty-two week high of $35.56.

Analysts Set New Price Targets

A number of brokerages have issued reports on ELMD. B. Riley raised Electromed to a "strong-buy" rating in a research report on Thursday, May 15th. Loop Capital set a $36.00 target price on Electromed in a research report on Wednesday. Wall Street Zen cut Electromed from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. Lake Street Capital assumed coverage on Electromed in a research report on Wednesday. They set a "buy" rating and a $36.00 target price for the company. Finally, Roth Capital upped their price target on Electromed from $29.00 to $35.00 and gave the stock a "buy" rating in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating and two have issued a Buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus price target of $36.25.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.